Objective To investigate the risk factors for early rebleeding from esophageal and gastric varices ( EGV) in patients with liver cirrhosis. Methods A total of 432 patients with liver cirrhosis who were admitted to Ningxia Medical University from January 2006 to December 2009 were included in the study. These patients were divided into control group ( n = 325) , who stopped bleeding after initial treatment, and study group ( n = 107) , who had rebleeding after initial treatment. The clinical and test data of the two groups were analyzed.Comparison of measurement data between the two groups was made by t test, while comparison of enumeration data was made by chi- square test; multiple comparison of constituent ratios was made. The univariate unconditional logistic regression model was used for analyzing the risk factors for rebleeding. Results There were significant differences in sex, smoking, hemoglobin ( Hb) level, white blood cell ( WBC) count, alanine aminotransferase level, aspartate aminotransferase level, and spleen thickness between the two groups ( P < 0. 05) . The univariate unconditional logistic regression analysis showed that percentage of neutrophils ( OR = 0. 976, P = 0. 034) , WBC count ( OR =1. 173, P = 0. 007) , portal vein width ( OR = 7. 530, P = 0. 001) , and Hb level ( OR = 1. 415, P = 0. 013) were positively correlated with rebleeding. Conclusion WBC count, percentage of neutrophils, Hb level, and portal vein width are positively correlated with rebleeding from EGV, and they are the risk factors for early rebleeding from EGV in patients with liver cirrhosis if their values are high.
[1]ZHANG J, DENG KX.Predicting risk of esophageal variceal bleeding caused by liver cirrhosis with spectral CT imaging in portal hypertension patients[J].Chin J Med Imaging Technol, 2012, 28 (12) :2201-2205. (in Chinese) 张军, 邓克学.能谱CT预测肝硬化门静脉高压患者并发食管静脉曲张破裂出血风险[J].中国医学影像技术, 2012, 28 (12) :2201-2205.
|
[2]CHEN H, ZHANG ZR, LIU ZQ.Prognosis of bleeding from esophageal and gastric varices in patients with hepatitis B cirrhosis:an analysis of 43 cases[J].J Clin Hepatol, 2007, 10 (5) :335-336. (in Chinese) 陈红, 张照如, 刘秩群.43例乙型肝炎肝硬化食管胃底静脉曲张破裂出血患者的预后分析[J].实用肝脏病杂志, 2007, 10 (5) :335-336.
|
[3]D'AMICO G, DE FRANCHIS R.Cooperative Study Group.Upper digestive bleeding in cirrhosis.Post-therapeutic outcome and prognostic indicators[J].Hepatology, 2003, 38 (3) :599-612.
|
[4]GARCIA-TSAO G, SANYAL AJ, GRACE ND, et al.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Hepatology, 2007, 46 (3) :922-938.
|
[5]GARCIA-TSAO G, GROSZMANN RJ, FISHER RL, et al.Portal pressure, presence of gastroesophageal varices and variceal bleeding[J].Hepatology, 1985, 5 (3) :419-424.
|
[6]YANG F, WANG BB, LI XH, et al.Logistic regression ananlysis on related factors of liver cirrhosis with esophageal-gastric varices bleeding[J].J Clin Hepatol, 2006, 22 (4) :269-270. (in Chinese) 杨方, 王彬彬, 李兴海, 等.Logistic回归分析肝硬化食管胃底静脉曲张破裂出血的相关因素[J].临床肝胆病杂志, 2006, 22 (4) :269-270.
|
[7]HAO YS, WANG JX, XIAO ZJ.Disorders of leucocytes basic principles&clinical practice[M].Shanghai:Shanghai Scientific&Technical Publishers, 2006:69-74. (in Chinese) 郝玉书, 王建祥, 肖志坚, 等.白细胞疾病基础理论与临床[M].上海:上海科学技术出版社, 2006:69-74.
|
[8]MENG L, LIU YX, YAO WT.Relation between neutrophil with leukocyte and gastroesophageal varices bleeding in patients with hepatocirrhosis[J].Shandong Med J, 2012, 52 (28) :26-27. (in Chinese) 孟磊, 刘云霞, 姚文暾.肝硬化患者中性粒细胞及白细胞与胃食管静脉曲张破裂出血的关系[J].山东医药, 2012, 52 (28) :26-27.
|
[9]BOURSIER J, ASFAR P, JOLY-GUILLOU ML, et al.Infection and variceal bleeding in cirrhosis[J].Gastroenterol Clin Biol, 2007, 31 (1) :27-38.
|
[10]LIU MX.The analysis of risk and prognostic factors in patients with the liver cirrhosis complicated with spontaneous bacterial peritonitis[D].Taiyuan:Shanxi Medical University, 2010:8. (in Chinese) 刘密霞.肝硬化并自发性腹膜炎的危险因素和影响预后因素的分析[D].太原:山西医科大学, 2010:8.
|
[11]POYNARD T, LEBREC D, HILLON P, et al.Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis:a prospective study of factors associated with rebleeding[J].Hepatology, 1977, 7 (3) :447-451.
|
[1] | Gengjie YAN, Yong LIN, Huiji SU, Hanxiao CHEN, Shaoqun BAN, Ailing WEI, Dewen MAO, Fuli LONG. Application and potential value of endogenous lipid mediators in liver failure[J]. Journal of Clinical Hepatology, 2023, 39(1): 211-217. doi: 10.3969/j.issn.1001-5256.2023.01.033 |
[2] | Mengyue SHANG, Yalin TONG, Yongzhong CHEN, Jie BAO. Influencing factors for acute kidney injury in acute liver failure and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2023, 39(2): 359-364. doi: 10.3969/j.issn.1001-5256.2023.02.016 |
[3] | Weiyuan FANG, Yi LU. Diagnosis and treatment of acute liver failure in children with Wilson's disease[J]. Journal of Clinical Hepatology, 2022, 38(2): 268-272. doi: 10.3969/j.issn.1001-5256.2022.02.004 |
[4] | Luxiang HAN, Huixin TANG, Zhenfeng ZHAO, Shanshan LI, Quanyi WANG, Lingbin KONG, Huiying BI, Zhenfeng SHU, Zhongping DUAN, Yu CHEN, feng HONG. Effect of exosomes from adult human liver-derived stem cells on concanavalin A-induced acute liver injury in mice[J]. Journal of Clinical Hepatology, 2022, 38(5): 1101-1105. doi: 10.3969/j.issn.1001-5256.2022.05.024 |
[5] | Li JIANG, Huimin LIU, Qing MAO. IgG4-related autoimmune hepatitis with subacute liver failure as the initial manifestation: A case report[J]. Journal of Clinical Hepatology, 2022, 38(1): 170-173. doi: 10.3969/j.issn.1001-5256.2022.01.028 |
[6] | Xiaomei QIN, Shuangjie LI. Etiology, diagnosis, and treatment of acute liver failure in neonates[J]. Journal of Clinical Hepatology, 2022, 38(2): 260-263. doi: 10.3969/j.issn.1001-5256.2022.02.002 |
[7] | Nengli WANG, Xinbao XIE. Liver transplantation for pediatric acute liver failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 278-281. doi: 10.3969/j.issn.1001-5256.2022.02.006 |
[8] | Xinbao XIE, Jianshe WANG. The diagnosis and treatment of pediatric acute liver failure should be taken seriously[J]. Journal of Clinical Hepatology, 2022, 38(2): 257-259. doi: 10.3969/j.issn.1001-5256.2022.02.001 |
[9] | Huan LIANG, Huiwen ZHANG. Inherited metabolic diseases causing acute liver failure in children[J]. Journal of Clinical Hepatology, 2022, 38(2): 273-277. doi: 10.3969/j.issn.1001-5256.2022.02.005 |
[10] | Xiaotong XU, Jinglan JIN. Death from acute hepatitis E in a non-pregnant middle-aged woman: A case report[J]. Journal of Clinical Hepatology, 2021, 37(4): 905-907. doi: 10.3969/j.issn.1001-5256.2021.04.036 |
[11] | Jingsheng MA, Yajun WU, Wentao YANG, Jiake HE, Hongfei ZHU, Yanfei RAO, Lin ZHONG, Qigen. LI. Successful liver transplantation in the treatment of acute liver failure caused by hemophagocytic syndrome: A case report[J]. Journal of Clinical Hepatology, 2021, 37(12): 2899-2901. doi: 10.3969/j.issn.1001-5256.2021.12.033 |
[12] | Fang YUAN, Jun SHI, Hailin TANG, Yiqun ZHOU, Fang XUE. HIV infection with acute liver failure as the main manifestation: A case report[J]. Journal of Clinical Hepatology, 2021, 37(7): 1670-1672. doi: 10.3969/j.issn.1001-5256.2021.07.039 |
[13] | Cao LiLi, Dong Yi, Xu ZhiQiang, Chen DaWei, Wang FuChuan, Gan Yu, Wang LiMin, Yan JianGuo, Wang Pu, Li AiQin, Zhang Min. Autosomal recessive polycystic kidney disease with congenital hepatic fibrosis: A report of 3 cases in a pedigree and literature review[J]. Journal of Clinical Hepatology, 2019, 35(1): 166-168. doi: 10.3969/j.issn.1001-5256.2019.01.033 |
[14] | Li ZhengXin, Xing Feng, Zhou Yang, Chen GaoFeng, Liu ChengHai. A case of congenital hepatic fibrosis with lgG4-related disease[J]. Journal of Clinical Hepatology, 2018, 34(10): 2192-2194. doi: 10.3969/j.issn.1001-5256.2018.10.026 |
[15] | Zhang Kai, Chen Hong, Lu MingXia, Wang FeiFei, Wan Hui, Zhang LiTing. One case of adult Still's disease with fever and jaundice as main clinical manifestations[J]. Journal of Clinical Hepatology, 2014, 30(6): 567-568. doi: 10.3969/j.issn.1001-5256.2014.06.023 |
[16] | Zhang AiMin, Xin ShaoJie. Virus infection and liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 729-731. |